Goodman Financial’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Goodman Financial's PFE Position: Q1 2026 in Review
Goodman Financial increased its Pfizer (PFE) stake by 3.4% in Q1 2026, buying an estimated $560K and bringing the position to 642,252 shares worth $18M. The position accounts for 3.1% of the portfolio, ranked #7.
Goodman Financial first reported a position in PFE in Q4 2017 and has held it in 14 quarters since. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Goodman Financial held 642,252 shares of Pfizer worth $18M as of Q1 2026.
- Goodman Financial bought 21,038 Pfizer shares in Q1 2026, an estimated $560K.
- Pfizer made up 3.1% of Goodman Financial's portfolio in Q1 2026, its #7 holding.
- Goodman Financial first reported a position in Pfizer in Q4 2017 and has held it in 14 quarters since.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Goodman Financial's 13F filing for Q1 2026, filed 6 May 2026.